This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Dr Vizcarrondo has disclosed no financial relationship relevant to this commentary. This commentary does not contain a discussion of an unapproved/investigative use of a commercial product/device.
In 2006, Ashley, a 6-year-old child with severe developmental disabilities, received treatment at Seattle Children’s Hospital (SCH) with high-dose estrogen and surgical removal of the child’s uterus and breast buds, in order to attenuate her growth to facilitate parental care-giving and to improve her future quality of life. Subsequently, a 20-member working group comprised of ethicists, legal experts, and community representatives was assembled at SCH to discuss ethical and legal aspects of growth attenuation in children like Ashley. In this report the …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.